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ABSTRACT 
 
Supercritical carbon dioxide has been used as a green solvent due to their well-known potential 
in biomaterials impregnation. The versatility of this technique enables the loading of implants 
with Active Pharmaceutical Ingredients which present several benefits when compared with 
traditional techniques to impregnate active compounds. In this review, we have summarized the 
recent progresses achieved in supercritical CO2 assisted impregnation of active compounds and 
therapeutic deep eutectic systems for biomedical applications.  
 
 
KEYWORDS 
Drug delivery systems, scCO2 assisted impregnation, THEDES, green chemistry; APIs; 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
INTRODUCTION 
Supercritical CO2 (scCO2) assisted impregnation has been used for loading active 
pharmaceuticals ingredients (APIs) in order to developed drug-eluting devices. 
The preparation of drug-release products using an impregnation process demands the use of a 
mobile phase dissolve and transport the APIs, which at the same time should be able to swell the 
polymeric matrix, allowing the diffusion of the drug into the polymer bulk, increasing the 
impregnation rate (1). Typically, the preparation of drug-release systems requires three steps: 
solubilization of the APIs in an adequate solvent, APIs diffusion through the polymer matrix and 
removal of the residual solvent (2). In Fig.1 the schematic representation of the three phases of 
the impregnation process is presented.  
 
Figure1. Schematic representation of the three phases of the impregnation process. 
 
In this sense, scCO2 assisted impregnation has proven to be feasible when the pharmaceutical 
compound is soluble in carbon dioxide and the polymer can be swollen by the supercritical fluid. 
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Different yields of impregnation can be obtained by scCO2 assisted impregnation. The most 
relevant factors that affect the yield directly are the operating pressure and temperature of the 
system, due to their influence on density and solvent power of CO2 but also on the diffusivity of 
the fluid phase. According to Kazarian et al.(3, 4) there are mainly two mechanisms which 
describe scCO2 assisted impregnation. One is highly dependent on the swelling ability of the 
polymeric matrix, when in contact of the scCO2 the drug is solubilized in CO2 and is placed in 
contact with the polymer, upon depressurization, the CO2 rapidly leaves the polymer matrix, the 
solubilized drug precipitates and is deposited within the polymeric matrix. The second 
mechanism is more dependent on the affinity of the CO2 with the drug and the drug towards the 
polymeric matrix. One of the major advances of this impregnation process is the fact that after 
impregnation, the drug-eluting device can be recovered free of any solvent residue and that the 
impregnation is carried under mild temperature and pressure conditions, which enables the 
impregnation of thermosensitive APIs (5, 6). In the last decades scCO2 has been claimed as a 
good candidate to replace conventional organic solvents in order to develop a sustainable 
chemical process and to meet the regulatory requirements (6, 7). Furthermore, it is non-
flammable, non-toxic, highly abundant and low cost solvent. CO2 can be easily separated from 
other compounds such as APIs and/or co-solvent, recovered and recycled (5).  
Due to the advantages of this process it has been applied in different fields from food to textile 
industries (5, 8, 9). Nowadays, scCO2 assisted impregnation process is commercially used to dye 
textiles (9) and to impregnate fungicide in wood (2, 10). In the last years, the higher number of 
publications suggest a growing interest on scCO2 assisted impregnation in biomedical and 
pharmaceutical fields, particularly in the processing of polymer-based systems for tissue 
engineering (7, 11-15) and drug delivery (1, 6, 16-18). In this review, we highlight the most 
recent advances and give some perspectives on what could be seen as the next big steps in the 
field. 
 
IMPREGNATION OF ACTIVE COMPOUNDS FOR BIOMEDICAL APPLICATIONS  
The interest and advantages of using scCO2 assisted impregnation process in the biomedical field 
are notorious. The process has been essentially used to disperse APIs into a polymeric matrix, 
but at the same time it favors the crystallization of the API in the amorphous form. Not only the 
impregnation in polymeric matrixes has been described in the literature but also the creation of 
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drug-eluting devices through the impregnation of the APIs in a preexistent polymer-based device 
is a very ingenious way to prepare new therapeutic delivery devices (5). Different studies suggest 
the advantage of this process compared with other methods, in different areas such as oral drug 
delivery, ophthalmic (lenses and subconjunctival implants) and tissue engineering (sutures and 
scaffolds) (5, 16, 17). In which concerns oral drug delivery this has been by far the most studied 
area. scCO2 assisted impregnation process has been intensively applied to prepare new drug 
loaded micro- or nanoparticles. This technique has not only improved the efficiency of drug 
loading but also it has enabled to improve the solubility and the dissolution rate of poorly water 
soluble drugs such as crystalline drugs (8, 19). García-González et al. (18) used scCO2 assisted 
impregnation process to impregnate ketoprofen, an anti-inflammatory agent in polysaccharide-
based aerogels in the form of microspheres, which may be used as carriers of poorly water 
soluble drugs for oral administration. The authors suggest the possibility of tuning drug loading 
and release by carefully choosing the polysaccharide used to prepare the aerogels. Another recent 
example. that can be found in literature are the use of scCO2 for impregnation to create 
microcontainers with APIs for oral drug delivery (1). 
Another interesting field in which scCO2 impregnation process has been applied, is in 
ophthalmic drug delivery. These systems aim at the increase in the contact time of the drugs in 
the aqueous humor which enhances their efficacy and their biocompatibility (20). Different 
studies show the successful impregnation of different drugs (acetazolamide (21-23), timolol 
maleate (21), flurbiprofen (24, 25), ciprofloxacin and dexamethasone 21-phosphate disodium 
(20)) in soft contact lens without modifying their important characteristics such as oxygen 
permeability, wettability and transparency. This would not be possible by any other means of 
impregnation, due to the low drug solubility in aqueous solutions and the strict limitations in the 
use of organic solvents. 
In the tissue engineering field, several studies demonstrate the advantage to use scCO2 
impregnation process in comparison with traditional processes for impregnation of antibacterial 
and anti-inflammatory compounds into commercial hydrogels, scaffolds and films, based on 
chitosan, collagen/cellulose, agarose and hyaluronic acid (25-27). In particular, the results of this 
studies suggest that using scCO2 impregnation was observed higher drug loadings and a more 
efficient drug release (25-27). 
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Biodegradable and non-degradable sutures fibers have been also impregnated by scCO2. The 
impregnation time to reach the maximal loading drug is relatively low, around one hour (2, 28, 
29). Champeau et al. in a recent study, studied the influence of scCO2 impregnation process in 
the tensile properties of the sutures made of poly-l-lactide (PLLA), poly (ethylene terephthalate) 
(PET) and polypropylene (PP) with two anti-inflammatory drugs namely ketoprofen and aspirin 
(2, 30).  
scCO2 assisted impregnation process has been a valuable tool in the development of other 
medical devices. Different commercial catheters and stents (from silicone and/or polyurethane) 
have been successfully impregnated with antibacterial, antimicrobial and antifungal drugs with 
the objective to decrease the risk of infection upon implantation (31-33). Various patents claim 
the use of this process for impregnation for example, for up to 25% of benzocaine into 
polyurethane-based catheter, under mild conditions (40°C; 80 bar) (31) and triclosan into 
silicone-based stent (33). On the same field, Barros et al. (17) developed of a ketoprofen-eluting 
biodegradable ureteral stent. The study involved a variety of biodegradable natural polymers in 
different concentrations and the results demonstrated that in fact different polymer matrixes 
render different impregnation yields at the same operating conditions. These systems have also 
shown to be effective carriers for the delivery of anti-cancer drugs targeting upper urinary tract 
urothelial tumors (16). To avoid the problems of the conventional method of drug administration 
via drug instillation, the authors proposed the use of biodegradable ureteral stents impregnated 
by scCO2 with four different anti-cancer drugs (paclitaxel, doxorubicin, epirubicin and 
gemcitabine). The anti-cancer drugs eluted by the degradable stent showed to be able to reduce 
75% of urothelial cancer cell (T24) after 72 hours, in vitro, with no toxicity observed in the non-
cancer cells (HUVEC cells), which was used as a control.  
A new trend in which concerns supercritical impregnation has to do with the coupling and 
integration of processes. Namely, the extraction of natural active compounds from plants 
followed by their impregnation in suitable polymeric matrices is becoming a focus of attention 
for scientist in the field. For example, Fanovich et al. investigated an integrated supercritical 
fluid extraction and impregnation process in order to fabricate microporous polycaprolactone-
hydroxyapatite (PCL-HA) scaffolds with antibacterial activity after impregnation with Usnea 
lethariiformis extract (34). The authors obtained a PCL–HA scaffolds with Usnea extract with a 
yield of impregnation up to 5.9 wt.%, and the antibacterial activity of scaffolds was confirmed. 
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The use of natural extracts rather than synthetic antibacterial molecules may render 
products with an enhanced biocompatibility. 
Industrial implementation of supercritical fluid impregnation has been validated for wood 
treatment and textile dyeing. In our opinion, scCO2 assisted impregnation processes should soon 
start to be scaled-up in other fields, but especially for biomedical applications as the high added 
value of the products is indisputable the translation of the processes from bench to industrial 
scale urges. The recent studies clearly demonstrate that new processes using CO2 around and 
below critical point, coupled with semi-finished medical devices aiming new applications may 
see interesting breakthroughs in the coming years.  
 
IMPREGNATION OF THERAPEUTIC DEEP EUTECTIC SYSTEMS 
Deep eutectic solvents (DES) appear as a new class of solvents that can be simply obtained 
via mixing of two or more components, which at a certain molar ratio  interact through 
hydrogen bonding and lead to a decrease in the overall melting temperature of the system 
when compared to the individual components.(35-37) This family of solvents presents several 
advantages that turn them into promising alternative solvents, such as their low cost, both in 
which concerns production and raw materials, ease of preparation, negligible vapor pressure and 
non-flammability.(36-39) Thus, DES are generally called tailored made solvents due to the wide 
variety of compounds available coupled with the different arrangements of molecules that can be 
done and which may lead to up to 106 combinations.(36, 40, 41) 
Among the compounds that can be used to form DES appear the ones that are involved in 
metabolic pathways. This subclass of DES has been termed natural deep eutectic solvents 
(NADES) and include the primary metabolites, such as organic acids, amino acids and 
sugars ( e.g., choline chloride, citric acid, ascorbic acid, sucrose, tartaric acid, glucose, 
sucrose and xylose”. (35-37) Later on, Stott and co-workers, introduced the use of DES in 
transdermal devices, being nowadays well-stablished the potential of these solvents to 
dissolve model drugs, by increasing their solubility, permeation and absorption.(36, 42-44) 
These can hence be called therapeutic deep eutectic systems (THEDES), since the eutectic 
system contain an active pharmaceutical ingredient (API’s) as one of the DES components. 
The development of innovative, more effective and specialized release dosage is an emergent 
need to improve the poor drug solubility and bioavailability, avoiding high dosage 
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concentrations which inherently lead to severe side effects. THEDES have been attracting 
significant attention due to their high stabilization and solubilization power strength of a wide 
range of compounds such as the ones poorly water soluble.(36, 42, 43, 45) Up to now, several 
compounds have been reported to be successful included in DES which is an invaluable 
challenge in healthcare worldwide, as they increase the bioavailability of API’s. The API’s can 
be included in DES either by solubilizing them in the eutectic mixture either by using them as 
part of the mixture, i.e. being an eutectic component.(36, 42, 43) 
There is always, however, the need to develop delivery systems and new carriers for drug 
delivery. The coupling of THEDES with polymeric material has been recently reported and 
brings new exciting possibilities for the production of suitable pharmaceutical systems. By 
doping polymers with THEDES and subjecting the mixture to scCO2, a foaming/sintering 
process takes place due to the plasticizing properties of THEDES, rendering polymeric matrices 
with enhanced porosity being a viable alternative for drug delivery systems.(36, 42, 44) 
Subcritical fluid sintering is a process which takes place at subcritical conditions and it is 
based on the slight plasticization of the polymeric particles which are fused together, 
creating a 3D architecture. Recent results show that it is possible to solubilize dexamethasone 
in a DES based on choline chloride:ascorbic acid. This system is particularly relevant in the case 
of bone tissue engineering as ascorbic acid and dexamethasone are known to act on the 
differentiation of stem cells in the osteogenic lineage. A controlled delivery system based on a 
starch polymer blend was impregnated with the THEDES choline chloride:ascorbic acid: 
dexamethasone by supercritical fluid sintering (Figure 2). The results obtained corroborated the 
previous one and suggested the plasticization effect of THEDES as well as an increase on the 
porosity and surface area of the final construct.(42, 44)  
Impregnation of drugs in polymeric matrices using supercritical CO2 is a well described and 
studied method, with many examples using ibuprofen as a model nonsteroidal anti-inflammatory 
drug (NSAID)(46, 47). On the other hand, the impregnation of therapeutic DES in polymers 
using scCO2 is still an area under development, particularly due to the lack of solubility 
measurements on the binary systems THEDES + CO2. In a preliminary work we have evaluated 
the possibility to incorporate a THEDES system composed of menthol:ibuprofen 3:1 in alginate 
sponges prepared by freeze drying. The dissociation/precipitation of THEDES in its components 
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was never observed throughout the work, which means that THEDES and CO2 behave as a 
pseudo-binary mixture. 
VLE experiments were carried out at two different pressures, at 10 MPa and 15 MPa, 
bellow and above the supercritical region of THEDES respectively. At 15 MPa, the mixture 
THEDES/CO2 presents only one phase, meaning that a high amount of THEDES is 
available for impregnation, thus increasing diffusion driving force. In Figure 3 it is observed 
the release profile of ibuprofen from alginate sponges in a PBS solution for different 
impregnation times at 15 MPa. As expected impregnation time influences the maximum amount 
of THEDES impregnated in the alginate sponges. The maximum impregnation amount is 
achieved at 3h with a value of 148 mgIbuprofen/gAlginate for 15 MPa. Further studies will be 
necessary to carry out a thorough characterization of the systems. Nonetheless, we can envisage 
that the possibility of coupling these new therapeutic agents with a technology that presents 
significant advantages in comparison with traditional impregnation techniques may open in the 
near future new opportunities for the preparation of enhanced drug delivery systems. 
Seeking of new delivery systems based on polymeric matrices loaded with DES is hence 
attracting widespread and technological interests. The invaluable potential and high flexibility of 
the systems render them a guarantee of success that will surely find its way for a strong 
appearance in biomaterials science for different applications depending on the DES properties. 
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Figure 2. (A) Schematic representation of the preparation of DES and its respective 
impregnation in polymeric matrix. (B) Micro-computed tomography cross-section of SPCL (B1), 
SPCL + choline chloride:ascorbic acid: dexamethasone (B2). 
 
Figure 3. Impregnation amount of ibuprofen, from alginate hydrogels impregnated with 
THEDES at 15 MPa during different periods of time (10, 30, 60, 180 and 360 minutes). Values 
were obtained through release tests of the impregnated alginate sponges in PBS medium and 
ibuprofen concentration was obtained by measuring UV absorbance (at 265 nm) of aliquots 
taken at different time intervals.  
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